Loading…
SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.
Also known as: NERVGEN PHARMA CORP., NervGen Pharma Corp., NERVGEN PHARMA CORP.
Firm Income Reported for This Client
$540K
Not substituted for client expenses
Summary
NERVGEN PHARMA CORP. (NGEN) is an organization. Its political footprint includes $540K in lobbying-firm income reported for this client. Lobbying activity focuses on Defense, Budget/Appropriations, Health Issues, Veterans. Political activity spans from 2021 to 2026.
SEC filings: SEC EDGAR